A clinical trial among people destined to develop early-onset Alzheimer’s disease and led by WashU Medicine researchers shows eliminating amyloid from the brain may prevent cognitive symptoms.
“¿Te puedo contar algo?”, an evening-length concert featuring new and original works by MFA candidates Tess Angelica Losada-Tindall and Lourdes del Mar Santiago Lebrón in Arts & Sciences, will explore the nature, power and necessity of grief March 21 and 22 in WashU’s Edison Theatre.
Jessica Backman-Levy (left), at the Brown School, and Beryne Odeny, MD, PhD, at the School of Medicine, have been selected to participate in a yearlong program aimed at advancing women into senior leadership positions in global health.
The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.
The ad hoc committee established by the WashU Board of Trustees to review the university’s policies and guidelines governing on-campus protests and demonstrations has completed its work.
Wilmetta Toliver-Diallo never stops her work on behalf of students. When she is not helping students apply for competitive fellowships, she is lecturing in the Department of African and African American Studies. And when she is not mentoring Mellon Mays fellows, she’s co-hosting dinners for her neighbors on the South 40.
Rob Bilott, the attorney who exposed DuPont’s water contamination cover-up, will speak April 7 for the Assembly Series. “Dark Waters,” a film based on his fight for justice, screens in advance.
Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.
